US Stock MarketDetailed Quotes

ENLV Enlivex Therapeutics

Watchlist
  • 1.307
  • -0.054-3.93%
Trading Jun 3 11:45 ET
27.27MMarket Cap-837P/E (TTM)

Enlivex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
1.80%-23.52M
-9.53%-5.28M
17.50%-5.44M
24.26%-7.02M
-76.93%-5.78M
-36.55%-23.95M
26.90%-4.82M
-56.94%-6.59M
-110.27%-9.27M
-39.70%-3.27M
Net income from continuing operations
6.41%-29.07M
-26.51%-9.1M
-4.01%-5.96M
31.48%-6.79M
12.24%-7.22M
-114.68%-31.06M
-51.79%-7.19M
-67.44%-5.73M
-218.95%-9.91M
-157.03%-8.23M
Operating gains losses
-118.31%-363K
-52,175.00%-2.09M
103.52%102K
-91.99%234K
-29.20%1.39M
135.47%1.98M
99.88%-4K
-360.89%-2.9M
344.35%2.92M
606.70%1.97M
Depreciation and amortization
7.46%835K
-9.50%200K
11.46%214K
20.45%212K
11.17%209K
42.31%777K
47.33%221K
22.29%192K
44.26%176K
60.68%188K
Other non cash items
494.46%4.94M
1,982.52%4.29M
0.93%216K
0.00%226K
12.43%208K
101.21%831K
-5.94%206K
145.98%214K
310.91%226K
255.77%185K
Change In working capital
-326.12%-1.82M
-14.44%1.02M
-135.68%-415K
58.15%-1.41M
-155.11%-1.01M
159.25%804K
320.15%1.19M
251.24%1.16M
-261.00%-3.38M
105.74%1.83M
-Change in prepaid assets
118.71%608K
154.13%262K
-46.74%515K
47.66%-661K
-53.50%492K
122.26%278K
24.14%-484K
332.45%967K
-187.05%-1.26M
331.84%1.06M
-Change in payables and accrued expense
-179.43%-1.47M
-59.24%845K
-331.31%-687K
69.30%-450K
-224.37%-1.18M
7,816.67%1.85M
6,587.10%2.07M
196.12%297K
-230.93%-1.47M
36.01%948K
-Change in other current liabilities
27.98%-955K
77.89%-88K
-140.59%-243K
53.38%-303K
-81.36%-321K
-1,478.57%-1.33M
-703.03%-398K
-129.55%-101K
-1,126.42%-650K
-233.96%-177K
Cash from discontinued investing activities
Operating cash flow
1.80%-23.52M
-9.53%-5.28M
17.50%-5.44M
24.26%-7.02M
-76.93%-5.78M
-36.55%-23.95M
26.90%-4.82M
-56.94%-6.59M
-110.27%-9.27M
-39.70%-3.27M
Investing cash flow
Cash flow from continuing investing activities
-141.53%-25.97M
243.78%4.14M
-91.04%3.95M
92.95%-2.7M
-152.53%-31.35M
262.79%62.52M
46.20%-2.88M
207.46%44.04M
-414.03%-38.32M
200.14%59.67M
Net PPE purchase and sale
98.73%-103K
101.70%44K
97.56%-29K
101.29%44K
82.98%-162K
-399.82%-8.12M
-149.85%-2.58M
-891.67%-1.19M
-1,036.79%-3.4M
-450.29%-952K
Net investment purchase and sale
-136.61%-25.87M
1,486.78%4.09M
-91.21%3.97M
92.14%-2.75M
-151.44%-31.18M
292.06%70.65M
93.16%-295K
213.15%45.23M
-379.33%-34.92M
202.04%60.63M
Cash from discontinued investing activities
Investing cash flow
-141.53%-25.97M
243.78%4.14M
-91.04%3.95M
92.95%-2.7M
-152.53%-31.35M
262.79%62.52M
46.20%-2.88M
207.46%44.04M
-414.03%-38.32M
200.14%59.67M
Financing cash flow
Cash flow from continuing financing activities
140.00%360K
0
0
-16.00%42K
536.00%318K
-99.75%150K
0
-25.37%50K
2,400.00%50K
-99.92%50K
Net common stock issuance
--360K
--0
--0
--42K
--318K
--0
--0
--0
--0
--0
Proceeds from stock option exercised by employees
--0
--0
--0
--0
--0
-98.08%150K
--0
-25.37%50K
2,400.00%50K
-99.35%50K
Cash from discontinued financing activities
Financing cash flow
140.00%360K
--0
--0
-16.00%42K
536.00%318K
-99.75%150K
--0
-25.37%50K
2,400.00%50K
-99.92%50K
Net cash flow
Beginning cash position
332.77%50.36M
-95.92%2.37M
-81.21%3.86M
-80.11%13.55M
332.77%50.36M
65.94%11.64M
148.86%58.05M
51.29%20.55M
1,160.94%68.09M
65.94%11.64M
Current changes in cash
-226.88%-49.13M
85.16%-1.14M
-103.98%-1.49M
79.63%-9.68M
-165.21%-36.81M
669.50%38.72M
35.56%-7.69M
267.98%37.5M
-709.97%-47.54M
5,673.05%56.46M
Effect of exchange rate changes
--0
----
----
----
----
--0
----
----
----
----
End cash Position
-97.57%1.23M
-97.57%1.23M
-95.92%2.37M
-81.21%3.86M
-80.11%13.55M
332.77%50.36M
332.77%50.36M
148.86%58.05M
51.29%20.55M
1,160.94%68.09M
Free cash flow
25.93%-23.76M
28.58%-5.28M
29.74%-5.47M
44.28%-7.06M
-40.87%-5.95M
-67.34%-32.08M
2.95%-7.4M
-80.12%-7.78M
-169.10%-12.67M
-67.97%-4.22M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 1.80%-23.52M-9.53%-5.28M17.50%-5.44M24.26%-7.02M-76.93%-5.78M-36.55%-23.95M26.90%-4.82M-56.94%-6.59M-110.27%-9.27M-39.70%-3.27M
Net income from continuing operations 6.41%-29.07M-26.51%-9.1M-4.01%-5.96M31.48%-6.79M12.24%-7.22M-114.68%-31.06M-51.79%-7.19M-67.44%-5.73M-218.95%-9.91M-157.03%-8.23M
Operating gains losses -118.31%-363K-52,175.00%-2.09M103.52%102K-91.99%234K-29.20%1.39M135.47%1.98M99.88%-4K-360.89%-2.9M344.35%2.92M606.70%1.97M
Depreciation and amortization 7.46%835K-9.50%200K11.46%214K20.45%212K11.17%209K42.31%777K47.33%221K22.29%192K44.26%176K60.68%188K
Other non cash items 494.46%4.94M1,982.52%4.29M0.93%216K0.00%226K12.43%208K101.21%831K-5.94%206K145.98%214K310.91%226K255.77%185K
Change In working capital -326.12%-1.82M-14.44%1.02M-135.68%-415K58.15%-1.41M-155.11%-1.01M159.25%804K320.15%1.19M251.24%1.16M-261.00%-3.38M105.74%1.83M
-Change in prepaid assets 118.71%608K154.13%262K-46.74%515K47.66%-661K-53.50%492K122.26%278K24.14%-484K332.45%967K-187.05%-1.26M331.84%1.06M
-Change in payables and accrued expense -179.43%-1.47M-59.24%845K-331.31%-687K69.30%-450K-224.37%-1.18M7,816.67%1.85M6,587.10%2.07M196.12%297K-230.93%-1.47M36.01%948K
-Change in other current liabilities 27.98%-955K77.89%-88K-140.59%-243K53.38%-303K-81.36%-321K-1,478.57%-1.33M-703.03%-398K-129.55%-101K-1,126.42%-650K-233.96%-177K
Cash from discontinued investing activities
Operating cash flow 1.80%-23.52M-9.53%-5.28M17.50%-5.44M24.26%-7.02M-76.93%-5.78M-36.55%-23.95M26.90%-4.82M-56.94%-6.59M-110.27%-9.27M-39.70%-3.27M
Investing cash flow
Cash flow from continuing investing activities -141.53%-25.97M243.78%4.14M-91.04%3.95M92.95%-2.7M-152.53%-31.35M262.79%62.52M46.20%-2.88M207.46%44.04M-414.03%-38.32M200.14%59.67M
Net PPE purchase and sale 98.73%-103K101.70%44K97.56%-29K101.29%44K82.98%-162K-399.82%-8.12M-149.85%-2.58M-891.67%-1.19M-1,036.79%-3.4M-450.29%-952K
Net investment purchase and sale -136.61%-25.87M1,486.78%4.09M-91.21%3.97M92.14%-2.75M-151.44%-31.18M292.06%70.65M93.16%-295K213.15%45.23M-379.33%-34.92M202.04%60.63M
Cash from discontinued investing activities
Investing cash flow -141.53%-25.97M243.78%4.14M-91.04%3.95M92.95%-2.7M-152.53%-31.35M262.79%62.52M46.20%-2.88M207.46%44.04M-414.03%-38.32M200.14%59.67M
Financing cash flow
Cash flow from continuing financing activities 140.00%360K00-16.00%42K536.00%318K-99.75%150K0-25.37%50K2,400.00%50K-99.92%50K
Net common stock issuance --360K--0--0--42K--318K--0--0--0--0--0
Proceeds from stock option exercised by employees --0--0--0--0--0-98.08%150K--0-25.37%50K2,400.00%50K-99.35%50K
Cash from discontinued financing activities
Financing cash flow 140.00%360K--0--0-16.00%42K536.00%318K-99.75%150K--0-25.37%50K2,400.00%50K-99.92%50K
Net cash flow
Beginning cash position 332.77%50.36M-95.92%2.37M-81.21%3.86M-80.11%13.55M332.77%50.36M65.94%11.64M148.86%58.05M51.29%20.55M1,160.94%68.09M65.94%11.64M
Current changes in cash -226.88%-49.13M85.16%-1.14M-103.98%-1.49M79.63%-9.68M-165.21%-36.81M669.50%38.72M35.56%-7.69M267.98%37.5M-709.97%-47.54M5,673.05%56.46M
Effect of exchange rate changes --0------------------0----------------
End cash Position -97.57%1.23M-97.57%1.23M-95.92%2.37M-81.21%3.86M-80.11%13.55M332.77%50.36M332.77%50.36M148.86%58.05M51.29%20.55M1,160.94%68.09M
Free cash flow 25.93%-23.76M28.58%-5.28M29.74%-5.47M44.28%-7.06M-40.87%-5.95M-67.34%-32.08M2.95%-7.4M-80.12%-7.78M-169.10%-12.67M-67.97%-4.22M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg